ANESTHETIC MANAGEMENT OF CONSTRICTIVE PERICARDITIS FOR PERICARDIECTOMY

1. DEFINITION AND ETIOLOGY

• Infectious: Tuberculosis (most common in developing world/India), viral, bacterial
• Post-cardiac surgery (most common cause in Western countries)
• Radiation therapy (breast cancer, Hodgkin's lymphoma - may manifest decades later)
• Connective tissue disorders (scleroderma, rheumatoid arthritis)
• Uraemia/chronic renal failure
• Idiopathic (post-viral)
• Trauma, malignancy, drugs (procainamide, hydralazine)

Exam tip: In India, TB is the most common cause. Post-radiation constriction carries the highest operative mortality.

2. PATHOPHYSIOLOGY (HIGH YIELD)

Key Hemodynamic Features:

Hemodynamic Profile:

• Low cardiac output with compensatory tachycardia and peripheral vasoconstriction
• Elevated CVP/JVP with hepatomegaly, ascites, peripheral edema (right heart failure picture)
• Near-normal systolic function of the ventricles
• Severely restricted diastolic filling - preload dependent, yet preload limited

Comparison with Cardiac Tamponade (Examiner's Favourite):

3. CLINICAL FEATURES

Symptoms:

• Exertional dyspnoea, orthopnoea (low CO severely limits exercise tolerance)
• Fatigue, weakness, anorexia
• Abdominal distension (ascites)
• Peripheral oedema

Signs:

• Raised JVP with Kussmaul's sign
• Pulsus paradoxus (>10 mmHg fall in SBP on inspiration)
• Loud, early S3 ("pericardial knock" - due to abrupt cessation of early rapid filling)
• Hepatomegaly, ascites, peripheral oedema
• Low-grade fever if infective

4. PREOPERATIVE ASSESSMENT AND OPTIMISATION

Cardiovascular Assessment:

• ECG: Low voltage complexes, non-specific ST-T changes, AF (in 20-30%)
• Chest X-ray: Pericardial calcification (eggshell appearance, best on lateral view), pleural effusion, normal or small cardiac silhouette
• 2D Echocardiography + Doppler - the most useful non-invasive investigation:
  • Pericardial thickening (>3-4 mm)
  • Septal bounce (respiratory variation of IVS - "septal shudder")
  • Inferior vena cava (IVC) dilatation with no respiratory variation
  • Respiratory variation of mitral E velocity >25% (key Doppler finding)
  • Tissue Doppler Imaging (TDI): e' velocity >8 cm/s (distinguishes from restrictive cardiomyopathy - where e' is reduced)
  • Normal or elevated annular e' velocity is a hallmark of CP (the myocardium itself is normal)
• CT/MRI chest: Gold standard for confirming pericardial thickening (>4 mm) and calcification. MRI also shows inflammation (useful in transient CP)
• Cardiac catheterization: Reserved for diagnostic uncertainty. Shows:
  • Diastolic pressure equalization within 5 mmHg in all chambers
  • "Square root" sign (dip and plateau) in ventricular pressure tracings
  • Discordant respiratory variation of RV and LV peak systolic pressures (RV increases on inspiration, LV decreases - ventricular interdependence)

Coronary Angiography:

• Mandatory in patients >50 years preoperatively to exclude concomitant CAD (Harrison's, 2025)
• Required before median sternotomy regardless of age in patients with risk factors

Assess Functional Class and Organ Dysfunction:

• Liver function tests - hepatic congestion may cause coagulopathy (check PT, INR)
• Renal function - secondary impairment from low CO and venous congestion
• Nutritional status - protein-losing enteropathy/ascites → hypoalbuminaemia
• Respiratory function - pleural effusions, reduced lung compliance

Preoperative Optimisation:

• Optimise fluid balance - gentle diuresis for gross oedema (but avoid excessive diuresis which reduces already limited preload)
• Treat AF - rate control or rhythm control; maintain sinus rhythm if possible
• Anti-tubercular therapy (ATT) if TB-related CP; surgery can proceed once on adequate ATT
• Nutritional correction if malnourished
• Correct coagulopathy if present (liver disease, nutritional deficiency)
• STOP ACE inhibitors/ARBs (vasodilator → BP drop on induction)
• Anti-anxiety premedication (minimal respiratory depression preferred)

High-risk Features (Warn Patient and Surgeon):

• Prior radiation therapy (friable tissues, higher risk of RV laceration)
• Severe calcification with myocardial penetration
• AF with ventricular dysfunction
• Hepatic/renal failure
• NYHA Class III/IV

5. ANAESTHETIC GOALS - THE HAEMODYNAMIC TARGET (CORE CONCEPT)

The "4 F Rule" (Fast, Full, Strong, Forward):

Additional goal: Avoid raised intrathoracic pressure - positive pressure ventilation reduces venous return and worsens haemodynamics.

6. MONITORING

Standard (ASA/IAC Minimum):

• SpO2, ETCO2, ECG (5-lead), temperature

Invasive Monitoring (Mandatory for Pericardiectomy):

TEE (Intraoperative) - High-Yield for Exam:

• Confirm diagnosis intraoperatively
• Assess pericardial thickness and calcification
• Monitor septal bounce (disappears after successful pericardiectomy)
• Assess ventricular filling after decortication (watch for sudden RV/LV dilatation)
• Guide fluid management
• Detect complications: RV/LV laceration, cardiac herniation, wall motion abnormalities
• Post-bypass assessment of ventricular function

A 2024 JACC State-of-the-Art Review (Al-Kazaz et al., PMID 39084831) recommends multidisciplinary evaluation including anaesthesia, cardiology, and cardiac surgery before pericardiectomy, and highlights TEE as integral to the operative team.

7. PREMEDICATION

• Avoid heavy sedation - risk of respiratory depression and hypoxia in already compromised patients
• Light anxiolysis: low-dose benzodiazepine (oral lorazepam 0.5-1 mg) if required
• Continue beta-blockers if on them (rate control)
• Atropine on standby (to treat bradycardia)
• H2 blocker / PPI for aspiration prophylaxis
• Antibiotic prophylaxis as per institutional protocol

8. INDUCTION OF ANAESTHESIA

Pre-induction Preparation:

1. Large-bore IV access x2 (14-16G), consider central line in situ
2. IV fluid loading before induction (500 mL crystalloid/colloid to maximise preload)
3. Arterial line in place and functional
4. Vasopressors and inotropes drawn up and ready:
   • Phenylephrine (or noradrenaline) - to treat sudden fall in SVR
   • Adrenaline - for inotropic support
   • Atropine/glycopyrrolate - for bradycardia
5. Defibrillator immediately available
6. Surgical team scrubbed and ready (rapid surgical relief available)
7. CPB pump primed and perfusionist present (may need emergency CPB)

Drug Selection:

Induction Sequence:

1. Pre-oxygenation (3 min 100% O2)
2. IV fluid top-up
3. Ketamine 1-2 mg/kg IV (or etomidate 0.2-0.3 mg/kg)
4. Fentanyl 1-2 mcg/kg
5. Low-dose midazolam 0.02-0.04 mg/kg (if using etomidate)
6. Muscle relaxant (succinylcholine or rocuronium)
7. Gentle laryngoscopy - avoid haemodynamic swings during laryngoscopy
8. Treat any bradycardia or hypotension immediately

9. AIRWAY MANAGEMENT

• Endotracheal intubation with cuffed ETT - standard approach
• Gentle positive pressure ventilation once intubated
• Settings: low tidal volume (6-8 mL/kg), high respiratory rate to minimise mean airway pressure and intrathoracic pressure elevation
• PEEP - use minimal or zero PEEP (reduces venous return)
• Avoid breath-holding, coughing, straining at intubation (raises intrathoracic pressure)
• An option before intubation in severely compromised patients: allow spontaneous ventilation (patient breathes spontaneously on mask/LMA until pericardium is opened), then convert to IPPV

10. MAINTENANCE OF ANAESTHESIA

Goals:

• Maintain HR 80-100 bpm (normal sinus rhythm preferred)
• Avoid bradycardia (fatal if SV is fixed)
• Maintain preload (ongoing IV fluids; assess CVP trends)
• Preserve SVR
• Minimal myocardial depression

Drug Regimen:

• Low-dose volatile agent (sevoflurane 0.5-1 MAC) or TIVA with ketamine/propofol (if propofol used, keep dose low with continuous vasopressor support)
• Opioid infusion (fentanyl or morphine)
• Non-depolarising muscle relaxant infusion (vecuronium, rocuronium)
• Vasopressor infusion (noradrenaline 0.05-0.2 mcg/kg/min) to maintain MAP
• Inotropes (adrenaline, dobutamine, milrinone) ready - may be needed especially post-CPB

Fluid Management:

• Maintain preload throughout
• Volume loading before CPB
• Post-CPB: carefully titrate fluids - the suddenly unloaded ventricles can dilate rapidly (the "low-pressure chamber" phenomenon)

11. SURGICAL APPROACH AND INTRAOPERATIVE EVENTS

Surgical Approach:

• Median sternotomy - most common approach (allows complete pericardiectomy and easy CPB access)
• Left anterolateral thoracotomy - alternative; may be used if previous sternotomy
• Extent of pericardiectomy: anterior pericardiectomy (between phrenic nerves) or radical pericardiectomy (including posterior and diaphragmatic portions, higher efficacy but technically demanding)

Cardiopulmonary Bypass (CPB):

• Not always required for pericardiectomy
• Indications for CPB:
  • Severe haemodynamic instability precluding off-pump approach
  • Need to strip visceral pericardium (epicardial decortication) in severe/calcified cases
  • RV or LV laceration requiring repair
  • Concomitant cardiac procedures (CABG, valve repair)
• 2024 JACC review recommends radical pericardiectomy on CPB as the preferred approach when feasible, given better outcomes (PMID 39084831)

Specific Intraoperative Hazards:

During Dissection (Pre-relief):

• Arrhythmias (VF, VT, AF, complete heart block) - due to mechanical manipulation of the heart and pericardium
• Haemorrhage - pericardium may be densely adherent to myocardium; risk of RV/LV laceration (RV most vulnerable - thin wall)
• Hypotension from manipulation compressing the heart

At Time of Pericardial Stripping:

• Acute RV dilation (most common and dangerous complication) - the suddenly decompressed RV, unaccustomed to filling at low pressure, acutely dilates leading to:
  • RV failure
  • LV underfilling
  • Haemodynamic collapse
  • Management: Reduce preload (venodilators like GTN), inotropes, pacing
• LV dilation - less common but can occur
• "Low cardiac output syndrome" immediately post-decortication despite successful pericardial removal - due to myocardial atrophy from long-standing constriction; may persist for weeks to months post-op

Coagulopathy and Bleeding:

• The raw exposed myocardium releases fibrinolytic activators → activation of coagulation and complement cascades
• Consumptive coagulopathy (DIC-like picture) can occur in addition to surgical bleeding
• Measures: antifibrinolytics (tranexamic acid), fresh frozen plasma, cryoprecipitate, platelets; cell salvage (autologous blood recovery)
• Monitor: TEG/ROTEM, PT/APTT, platelet count, fibrinogen

12. POST-BYPASS/POST-PERICARDIECTOMY MANAGEMENT

Expected Haemodynamic Changes After Pericardial Release:

• Sudden rise in BP (catecholamine surge - both endogenous and exogenously administered)
• Acute ventricular dilation (especially RV)
• Possible LV dysfunction (myocardial atrophy, stunning)

Management:

1. Reduce vasopressor infusions as SVR falls to normal
2. Titrate fluids carefully - avoid fluid overload in now-dilated ventricles
3. Inotropic support (dobutamine, milrinone for RV failure; adrenaline for combined failure)
4. Vasodilators (GTN infusion) if RV acutely dilates and fails
5. Pacing may be required for heart block or bradycardia
6. Defibrillation ready for ventricular arrhythmias
7. IABP or VAD - rarely, if refractory low output state
8. If on CPB: prolonged weaning may be required

Anticipated Post-Op Issues:

• Low output syndrome (may persist for weeks - myocardial atrophy)
• Residual elevated filling pressures (functional improvement is gradual, over weeks to months)
• Bleeding/haemorrhage requiring re-exploration
• Arrhythmias (AF, VT)
• Pleural effusion, pneumothorax

13. POSTOPERATIVE CARE (ICU)

Monitoring:

• Continuous ECG, SpO2, ETCO2 (if ventilated)
• Intra-arterial BP (usually maintain for at least 24-48 h)
• CVP, PAC (if inserted)
• Urine output (hourly)
• Cardiac output monitoring if available

Analgesia:

• Thoracic epidural analgesia (TEA) - highly beneficial for sternotomy pain; reduces splinting, aids respiratory function
  • However, epidural haemorrhage risk with coagulopathy must be excluded preoperatively
  • Insert pre-induction (if coagulation normal and patient cooperative) or post-operatively
• IV opioid PCA as alternative
• Parasternal nerve blocks (PEC blocks) gaining popularity for sternal analgesia

Ventilatory Support:

• Planned extubation in theatre or early extubation in ICU (if haemodynamically stable)
• In RV failure/low output: continue ventilation until haemodynamics stabilise

Fluid and Haemodynamic Management ICU:

• Goal-directed fluid therapy
• Wean vasopressors/inotropes as cardiac function improves
• Diuresis once haemodynamically stable (drain oedema/ascites accumulated from chronic CP)

Important ICU Observations:

• Drain output monitoring (cardiac tamponade risk post-op)
• Watch for delayed cardiac tamponade
• Liver function (if pre-existing hepatic congestion)
• Renal function

14. SPECIAL CONSIDERATIONS

TB-related CP:

• Continue ATT pre and postoperatively
• Typically requires 6-9 months ATT; surgery can be performed after 4-6 weeks of treatment initiation
• Steroid adjunct therapy (prednisolone) may reduce constriction progression (per ESC guidelines)

Radiation-induced CP:

• Highest operative mortality (up to 21% in some series)
• Associated myocardial fibrosis, valvular disease, coronary artery disease, pericardial fibrosis
• May need concomitant valve surgery or CABG
• Pericardium more densely adherent; higher bleeding risk
• Warn patient of guarded prognosis

Effusive-Constrictive Pericarditis:

• Combined features of tamponade and constriction
• After pericardiocentesis, physiology may shift from tamponade to constriction pattern
• Requires wide excision of both visceral and parietal pericardium

Paediatric CP:

• Most commonly TB-related
• Principles same; size-appropriate monitoring and dosing

Transient CP:

• Recent-onset constriction (reversible)
• Trial of anti-inflammatory therapy (NSAIDs + colchicine + steroids) for 2-3 months
• Surgery deferred unless severe or no resolution

15. COMPLICATIONS OF PERICARDIECTOMY

16. PROGNOSIS AND OUTCOMES

• Operative mortality: 5-10% at experienced centres; up to 21% for radiation-induced CP
• 5-year survival: ~70-80% overall; worse in radiation-induced CP
• Haemodynamic improvement begins immediately but functional improvement occurs over weeks to months (myocardial atrophy takes time to recover)
• Undiagnosed CP: 90% mortality - underscores the importance of early diagnosis (Liu et al., JCVA 2021, PMID 33722460)
• Better outcomes with: earlier surgery, idiopathic/infectious aetiology, lower NYHA class, radical complete pericardiectomy on CPB

SUMMARY: KEY EXAM POINTS AT A GLANCE

1. Physiology: Fixed SV, CO = HR x fixed SV; maintain HR, preload, SVR, contractility
2. Induction: Ketamine or etomidate; AVOID propofol/thiopentone
3. Ventilation: Low tidal volume, high RR, minimal PEEP to preserve venous return
4. Monitoring: Arterial line before induction, CVP, TEE mandatory
5. Biggest intraoperative risk: Acute RV dilation after pericardial stripping; coagulopathy/DIC
6. Post-relief: Expect sudden haemodynamic change; catecholamine surge, then possible RV failure
7. Analgesia: Thoracic epidural (if no coagulopathy) or opioid PCA
8. CPB: Preferred for radical pericardiectomy; have perfusionist ready even for off-pump cases
9. TB-CP: Most common in India; ensure ATT coverage perioperatively
10. Radiation CP: Highest risk group; associated coronary and valvular disease

REFERENCES

• Miller's Anesthesia, 10th Edition (2023), Chapter 50 - Cardiac Tamponade and Constrictive Pericarditis, pp. 7772-7773
• Harrison's Principles of Internal Medicine, 22nd Edition (2025), Chapter on Pericardial Disease
• Braunwald's Heart Disease, 12th Edition (2022)
• Liu VC, Fritz AV, Burtoft MA et al. Pericardiectomy for Constrictive Pericarditis: Analysis of Outcomes. J Cardiothorac Vasc Anesth. 2021;35(12). PMID: 33722460
• Al-Kazaz M, Klein AL, Oh JK et al. Pericardial Diseases and Best Practices for Pericardiectomy: JACC State-of-the-Art Review. J Am Coll Cardiol. 2024 Aug 6. PMID: 39084831

1. Definition and etiology (TB as most common in India)
2. Pathophysiology and hemodynamic features (ventricular interdependence, square root sign, Kussmaul's - all high-yield exam topics)
3. Comparison with cardiac tamponade (classic examiner's table)
4. Preoperative assessment and optimization
5. Anaesthetic goals - the "4F rule" (Fast, Full, Strong, Forward)
6. Monitoring (mandatory invasive monitoring, TEE role)
7. Premedication
8. Induction of anaesthesia - drug selection, Ketamine vs Etomidate as agents of choice, AVOID propofol/thiopentone
9. Airway and ventilation strategy (low TV, high RR, minimal PEEP)
10. Maintenance
11. Surgical approach and intraoperative hazards (especially acute RV dilation post-stripping)
12. Post-bypass/post-pericardiectomy management
13. ICU care including epidural analgesia
14. Special situations (TB-CP, radiation CP, effusive-constrictive)
15. Complications and prognosis

• CO = HR × fixed SV, therefore HR is the only modulator
• Ketamine is the induction agent of choice (sympathomimetic)
• TEE is mandatory intraoperatively
• Acute RV dilation immediately after pericardial stripping is the most feared intraoperative complication
• Coagulopathy/DIC occurs due to fibrinolytic activator release from raw myocardium
• Operative mortality 5-10% (up to 21% for radiation-induced)

PATHOPHYSIOLOGY OF AORTIC CROSS-CLAMPING AND UNCLAMPING, AND RENAL PROTECTION MEASURES

INTRODUCTION

PART 1: PATHOPHYSIOLOGY OF AORTIC CROSS-CLAMPING

A. Levels of Aortic Cross-Clamping

1. Supraceliac (above the coeliac axis)
2. Suprarenal (between the coeliac axis and renal arteries)
3. Infrarenal (below both renal arteries - most common, best tolerated)

B. Haemodynamic Response to Cross-Clamping

1. Afterload (SVR)

• The most dramatic and consistent effect of AoX is a sudden increase in systemic vascular resistance (SVR) and mean arterial pressure (MAP) due to abrupt impedance to aortic flow.
• Magnitude depends on clamp level:

2. Preload - Blood Volume Redistribution (KEY CONCEPT)

• AoX causes blood volume redistribution proximal to the clamp by passive venous recoil from vessels distal to occlusion.
• The net effect on preload depends on clamp level and splanchnic capacitance:

• Splanchnic circulation is occluded - it cannot absorb the redistributed blood volume
• Decrease in splanchnic arterial flow → decrease in venous capacitance by elastic recoil
• Result: Net increase in venous return, CVP, PCWP, and cardiac preload
• LV end-diastolic volume increases markedly

• Splanchnic circulation remains intact (above the clamp)
• Redistributed blood volume shifts into the compliant splanchnic vascular bed
• This dampens the expected preload increase
• Preload changes are variable and inconsistent

3. Cardiac Output

• With supraceliac/suprarenal AoX: The combination of increased preload AND afterload dramatically increases myocardial work
  • Normal hearts: coronary vasodilation compensates, CO may be maintained or increase
  • Diseased hearts (reduced EF, significant CAD): coronary vasculature already maximally dilated - cannot compensate - myocardial ischaemia and cardiac failure result
  • New LV wall motion abnormalities in 92% of patients with supraceliac clamp
• With infrarenal AoX: CO decreases 9-33%; usually clinically manageable

4. Heart Rate

• AoX itself has little to no direct effect on heart rate
• Baroreceptor activation from increased aortic pressure may reflexly reduce HR, contractility, and vascular tone

5. Myocardial Effects (Afterload Mismatch)

• Increased afterload → increased LV wall stress
• Impaired LV (common in the elderly) cannot handle the acute volume and pressure overload
• Afterload mismatch: increased afterload → increased LV end-systolic volume → reduced stroke volume
• This leads to progressive LV distension, subendocardial ischaemia, pulmonary oedema

6. Metabolic Effects

• Thoracic AoX decreases total body O2 consumption by ~50% (below-clamp ischaemia)
• O2 consumption ABOVE the clamp paradoxically also decreases (unclear mechanism)
• Mixed venous O2 saturation increases above clamp (O2 consumption decreases > CO falls)
• Distal to thoracic AoX: arterial BP, blood flow, and O2 consumption fall by 78-88%, 79-88%, and 62% respectively

C. Anaesthetic Management During Cross-Clamping

1. Control of proximal hypertension:
   • Vasodilators: Sodium nitroprusside (SNP) - bolus or infusion; nitroglycerin (GTN); nicardipine
   • Esmolol: Reduce HR to 60-65 bpm target to limit myocardial O2 demand
   • Deepening volatile anaesthesia
   • Thoracic epidural local anaesthetic (L.A. epidural at T6 level - provides sympathetic blockade, reduces SVR)
   • Important caution: Aggressive SVR reduction above the clamp can further compromise blood flow DISTAL to the clamp (visceral, spinal cord, renal ischaemia) - a critical balance must be maintained
2. Monitor for ischaemia:
   • Continuous ECG (5-lead, ST analysis)
   • TEE - LV wall motion abnormalities, LVEDA/LVESA, EF
   • PAC if required in complex cases (PCWP)

PART 2: PATHOPHYSIOLOGY OF AORTIC UNCLAMPING

A. The "Declamping Syndrome"

B. Mechanisms of Hypotension on Unclamping

1. Acute Fall in SVR (Central to the Response)

• Release of the clamp suddenly restores blood flow into the ischaemic, vasodilated distal vascular beds
• The ischaemic tissues distal to the clamp undergo reactive hyperaemia - maximal vasodilation from accumulated metabolic vasodilatory mediators:
  • CO2, lactic acid, adenosine, prostaglandins, oxygen free radicals, hypoxanthine
• This dramatically reduces SVR → acute fall in MAP

2. Reduced Preload (Pooling of Blood)

• Sudden redistribution of blood volume INTO the previously ischaemic distal beds ("third spacing")
• Venous pooling in dilated distal capacitance vessels
• Effective circulating volume decreases
• CVP and PCWP fall → reduced LV filling → reduced CO and BP

3. Metabolic Reperfusion Effects - "Washout Phenomenon"

• Release of accumulated ischaemic metabolites from distal tissues into the systemic circulation:
  • Lactic acidosis (metabolic acidosis)
  • Hyperkalaemia
  • Myocardial depressant factors (cytokines, TNF-α, interleukins)
  • Oxygen free radicals (ischaemia-reperfusion injury)
  • Adenosine (vasodilatory)
  • CO2 surge
• These directly depress myocardial contractility and further reduce BP

4. Ischaemia-Reperfusion (I/R) Injury

• Reperfusion after ischaemia paradoxically generates more injury than ischaemia alone
• Mechanisms: xanthine oxidase-mediated free radical generation, neutrophil activation, endothelial dysfunction, complement activation
• Affects: myocardium, kidneys, spinal cord, gut (mesenteric ischaemia)

5. Proximal Hypertension "Rebound"

• After unclamping, the proximal vasodilator therapy (SNP/GTN) that was reducing afterload now acts without the increased SVR of clamping → profound hypotension

C. Factors Affecting Severity of Declamping Hypotension

D. Haemodynamic Changes on Unclamping (Summary Table)

E. Anaesthetic Management During Unclamping

1. Communicate with surgeon - ensure adequate preparation time
2. IV fluid loading - administer 500-1000 mL crystalloid/colloid before release to expand intravascular volume
   • Infrarenal: moderate pre-load (~500 mL)
   • Supraceliac/suprarenal: more aggressive volume loading required
3. Wean and stop vasodilators (SNP/GTN) - discontinue before unclamping to avoid additive hypotension
4. Reduce volatile anaesthetic depth - lighten anaesthesia to improve sympathetic tone
5. Vasopressor/inotrope infusions ready: Noradrenaline, phenylephrine, dopamine, adrenaline
6. Sodium bicarbonate (NaHCO3 1-2 mEq/kg IV) - to buffer anticipated metabolic acidosis
7. Calcium gluconate/chloride - to manage hyperkalaemia and support myocardial contractility
8. Do NOT maintain elevated CVP/PCWP during clamp period (leads to significant overtransfusion)

• Request gradual, slow clamp release by surgeon (not sudden)
• If severe hypotension: reapply clamp or digital compression by surgeon while resuscitation continues
• Once haemodynamics stabilise, gradually remove clamp fully
• Treat metabolic acidosis (NaHCO3), hyperkalaemia (calcium, hyperventilation, bicarbonate)
• Monitor for arrhythmias (VF, VT) from hyperkalaemia

PART 3: RENAL PROTECTION DURING AORTIC CROSS-CLAMPING

A. Magnitude of the Problem

• Acute renal failure (ARF) occurs in ~3% of elective infrarenal aortic reconstructions
• Mortality from postoperative ARF exceeds 40%
• The incidence has remained largely unchanged despite improvements in perioperative care

B. Pathophysiology of Renal Ischaemia During AoX

C. Renal Protection Measures

1. MAINTAIN ADEQUATE PERFUSION PRESSURE AND VOLUME

• Most fundamental measure
• Goal: MAP ≥ 70-80 mmHg above the clamp
• Avoid hypovolaemia and hypotension at all times
• IV fluid optimisation before, during, and after clamping
• Volume loading before unclamping to prevent hypotensive reperfusion injury

2. MANNITOL (Most Widely Used)

• Dose: 0.25-0.5 g/kg IV bolus (12.5 g/70 kg is standard dose) before aortic cross-clamping
• Mechanisms of renal protection:
  • Induces osmotic diuresis - flushes tubular debris, reduces tubular cast formation
  • Improves renal cortical blood flow during infrarenal AoX
  • Reduces ischaemia-induced renal vascular endothelial cell oedema and vascular congestion
  • Free radical scavenger - reduces ischaemia-reperfusion injury
  • Decreases renin secretion
  • Increases renal prostaglandin synthesis (vasodilatory)
  • Reduces intracellular oedema of renal tubular cells
• Timing: Give before cross-clamping for optimal effect
• Caution: In patients with poor cardiac function - osmotic expansion of intravascular volume may precipitate pulmonary oedema

3. LOOP DIURETICS (Furosemide)

• Increase urine flow and decrease tubular oxygen demand
• May protect against tubular obstruction by casts
• Used particularly for patients with pre-existing renal insufficiency
• Requires increased electrolyte monitoring (hypokalaemia, hypomagnesaemia) and volume replacement
• Risk: Overuse → hypovolaemia → worsened renal perfusion (paradoxical harm)

4. DOPAMINE (Low-dose / "Renal dose")

• Dose: 1-3 mcg/kg/min
• Proposed mechanism: Dopamine-1 (DA1) receptor stimulation → renal afferent and efferent arteriolar vasodilation → increased RBF and GFR → increased urine output
• Reduces renal tubular sodium reabsorption (tubular DA1 receptors) → reduces tubular O2 consumption
• Clinical evidence: Highly controversial; no convincing evidence that low-dose dopamine improves postoperative renal outcomes
• Risks of dopamine in this context:
  • Positive inotropic and chronotropic effects → tachycardia → increased myocardial O2 consumption in patients with limited coronary reserve
  • Splanchnic vasoconstriction at higher doses
• Current status: Routine use is not evidence-based; commonly used as adjunct in suprarenal clamping

5. FENOLDOPAM MESYLATE

• A selective Dopamine-1 (DA1) receptor agonist - preferentially dilates renal and splanchnic vascular beds WITHOUT the adrenergic effects of dopamine
• Has shown promise as a renoprotective drug in some studies
• Avoids the tachycardia/arrhythmia side effects of dopamine
• Current evidence: Role not definitively established; used in suprarenal AoX cases
• May cause systemic hypotension (vasodilation)

6. N-ACETYLCYSTEINE (NAC)

• Free radical scavenger, antioxidant
• Theoretical benefit via reduction of ischaemia-reperfusion injury
• Some benefit in contrast nephropathy; limited data for AoX renal protection

7. AVOID NEPHROTOXINS

• Stop NSAIDs preoperatively
• Stop ACE inhibitors/ARBs preoperatively (reduce intrarenal autoregulation)
• Avoid aminoglycosides, contrast agents perioperatively
• Minimise vasopressor overuse (vasoconstriction worsens renal ischaemia)

8. MINIMISE CROSS-CLAMP TIME

• The duration of aortic cross-clamping is one of the strongest predictors of renal injury
• Shorter clamp time → less ischaemia → less ATN
• Surgeon proficiency and preparation of anastomosis before clamping is essential

9. MAINTAIN HAEMATOCRIT AND OXYGEN DELIVERY

• Anaemia reduces O2 delivery to ischaemic kidneys
• Target Hct ≥ 25-30% (especially before clamping)
• Avoid fluid overload vs. hypovolaemia balance

10. REGIONAL COOLING OF KIDNEYS (Surgical)

• Used for suprarenal/supraceliac procedures
• Ice slush instilled around the kidneys via retroperitoneal dissection
• Reduces renal metabolic rate and ischaemic injury

11. COLD RENAL PERFUSION (Surgical)

• For very long suprarenal clamp times
• Cold (4°C) crystalloid or Ringer's lactate solution perfused directly into renal arteries via cannulae
• Reduces renal core temperature → reduces metabolic demand

12. MINIMISE DISTAL AORTIC ISCHAEMIA - ADJUNCTS

• Left heart bypass (LHB) or partial CPB: For thoracoabdominal surgery - maintains distal aortic perfusion including renal arteries during proximal clamp
• Reduces clamp-to-organ ischaemia time
• Particularly important for Type I/II TAAA (Crawford classification)

13. EPIDURAL ANAESTHESIA (COMBINED TECHNIQUE)

• Renal sympathetic block (T6 epidural) theoretically reduces renal vasoconstriction
• However, studies show it does NOT prevent the severe impairment of renal perfusion and function during/after infrarenal AoX
• Primary benefit is postoperative analgesia and reduced systemic anaesthetic requirements

D. Summary Table: Renal Protection Strategies

KEY EXAM SUMMARY POINTS

1. Supraceliac AoX = most severe haemodynamic response (↑MAP 54%, EF falls 38%, 92% RWMA)
2. Infrarenal AoX = most common, best tolerated but still causes 38% fall in RBF despite systemic haemodynamics being near-normal
3. Blood volume redistribution distal-to-proximal is the key mechanism explaining preload changes
4. Unclamping: SVR ↓ + venous pooling + metabolite washout (acidosis, ↑K+, myocardial depressants) = hypotension
5. Prepare before unclamping: fluid load, wean vasodilators, reduce volatile, vasopressors ready, NaHCO3, slow release
6. Renal protection: Mannitol is the cornerstone (free radical scavenger + osmotic diuresis + cortical flow); minimise clamp time; maintain perfusion pressure; avoid nephrotoxins
7. Urine output does NOT predict renal protection - measure of flow not function
8. Strongest predictor of post-op renal failure: pre-existing renal insufficiency
9. ARF after aortic surgery: 3% incidence but >40% mortality - prevention is paramount
10. Epidural anaesthesia does NOT prevent renal vasoconstriction from infrarenal AoX

REFERENCES

• Barash, Cullen, Stoelting's Clinical Anaesthesia, 9th Edition - Chapter 40 (Anaesthesia for Vascular Surgery): Pathophysiology of Aortic Occlusion and Reperfusion
• Miller's Anaesthesia, 10th Edition - Chapter 52: Renal Function and Protection; Therapeutic Strategies for Thoracoabdominal Aortic Surgery
• Morgan & Mikhail's Clinical Anaesthesiology, 7th Edition - Chapter on Vascular Anaesthesia
• Gelman S. The pathophysiology of aortic cross-clamping and unclamping. Anaesthesiology. 1995;82(4):1026-1060 (Classic Reference - Examiner's Favourite)